Porcine dermis implants in soft-tissue reconstruction: current status
نویسندگان
چکیده
منابع مشابه
Porcine dermis implants in soft-tissue reconstruction: current status
Soft-tissue reconstruction for a variety of surgical conditions, such as abdominal wall hernia or pelvic organ prolapse, remains a challenge. There are numerous meshes available that may be simply categorized as either synthetic or biologic. Within biologic meshes, porcine dermal meshes have come to dominate the market. This review examines the current evidence for their use and the limitations...
متن کاملClinical evaluation of soft tissue surrounding prosthesis supported by implants
Clinical evaluation of soft tissue surrounding prosthesis supported by implants Dr. A. Fazel* - Dr. M. Rismanchian** *- Associate Professor of Prosthodontics Dept. - Faculty of Dentistry - Tehran University of Medical Sciences. **- Assistant Professor of Prosthodontics Dept. – Faculty of Dentistry - Isfahan University of Medical Sciences. Background and Aim: Nowadays, reconstruction and replace...
متن کاملTechniques for soft tissue management around the implants: a review
Dental implants, as a result of their excellent success rates and advantages over fixed or removable methods, have become the optimal treatment for replacing missing teeth. Surgical and restorative techniques that can reduce the loss of hard and soft tissues that often accompany implant placement are desirable. Achieving an esthetic outcome in tooth replacement and implant treatment requires a...
متن کاملTrabectedin for Soft Tissue Sarcoma: Current Status and Future Perspectives
UNLABELLED Trabectedin (ET743, Yondelis(®), manufactured by Baxter Oncology GmbH, Halle/Westfalen, Germany, for Janssen Products, LP, Horsham, PA), derived from the marine ascidian, Ecteinascidia turbinata, is a natural alkaloid with multiple complex mechanisms of action. On 23 October 2015, 15 years after the results of the first Phase 1 clinical trial using trabectedin for chemotherapy-resist...
متن کاملAdjuvant Chemotherapy of Soft Tissue Sarcoma—Current Status
It is acknowledged that, although improvements can be made in local control, e.g. by the use of adjuvant radiotherapy, the major challenge in the management of adult soft tissue sarcomas is the treatment of distant metastatic disease.We lack very effective drugs capable of providing long-term disease control once this event has occurred. Palliation is possible with doxorubicin, ifosfamide or co...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Biologics: Targets and Therapy
سال: 2014
ISSN: 1177-5475
DOI: 10.2147/btt.s46469